$18.8 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 10 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 157.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LNTH | Buy | LANTHEUS HLDGS INC | $8,256,000 | +848.7% | 100,000 | +485.6% | 43.89% | +277.2% |
| New | CBL & ASSOC PPTYS INC | $2,104,557 | – | 82,081 | +100.0% | 11.19% | – | |
| NVS | New | NOVARTIS AGsponsored adr | $2,024,000 | – | 22,000 | +100.0% | 10.76% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $2,015,640 | – | 9,000 | +100.0% | 10.72% | – |
| QQQ | New | INVESCO QQQ TRunit ser 1 | $1,540,464 | – | 4,800 | +100.0% | 8.19% | – |
| NVO | New | NOVO-NORDISK A Sadr | $1,113,980 | – | 7,000 | +100.0% | 5.92% | – |
| SPY | New | SPDR S&P 500 ETF TRtr unit | $1,023,475 | – | 2,500 | +100.0% | 5.44% | – |
| FRC | New | FIRST REP BK SAN FRANCISCO C | $727,480 | – | 52,000 | +100.0% | 3.87% | – |
| AMPY | AMPLIFY ENERGY CORP NEW | $6,547 | -21.8% | 953 | 0.0% | 0.04% | -68.8% | |
| CO | GLOBAL CORD BLOOD CORPORATIO | $0 | -100.0% | 279,495 | 0.0% | 0.00% | -100.0% | |
| CVNA | Exit | CARVANA COcl a | $0 | – | -150,000 | -100.0% | -9.50% | – |
| CCEL | Exit | CRYO-CELL INTL INC | $0 | – | -195,031 | -100.0% | -11.03% | – |
| Exit | CBL & ASSOC PPTYS INC | $0 | – | -78,316 | -100.0% | -24.16% | – | |
| LNDC | Exit | LIFECORE BIOMEDICAL INC | $0 | – | -373,778 | -100.0% | -32.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
| AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
| XPEL INC | 10 | Q4 2021 | 22.3% |
| TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
| AMERCO | 8 | Q4 2015 | 11.2% |
| NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
| MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
| CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
| LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
| CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.